BiosimulantBiosimulant
Docs
Search labs...
Sign inGet Started

Mpekris2017 - Role of vascular normalization in benefit from metronomic chemotherapy Lab

About lab

Role of vascular normalization in benefit from metronomic chemotherapy.Mpekris F1, Baish JW2, Stylianopoulos T3, Jain RK4.Author informationAbstractMetronomic dosing of chemotherapy-defined as frequen. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.

Runtime

Duration10
Comms Step1

Runs

Total0
Completed0
Failed0

Metadata

Packagempekris2017-role-of-vascular-normalization-in-benefit-from-metro
Created2026-05-16
Updated2026-05-16
angiogenesisbiomodels_ebichemotherapycurateddrug-responsefaithfulmicroenvironmentoncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisation

Manifest

{
  "io": {
    "inputs": [
      {
        "name": "initial_csc",
        "label": "Csc",
        "units": "native SBML value",
        "default": 1,
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.initial_csc",
        "description": "Initial Csc. Sets the initial value of bundled SBML symbol `Csc`."
      }
    ],
    "outputs": [
      {
        "name": "chemotherapy_level",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.chemotherapy_level",
        "description": "C observable. Maps to SBML symbol `C`."
      },
      {
        "name": "tumor_cells",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.tumor_cells",
        "description": "T observable. Maps to SBML symbol `T`."
      },
      {
        "name": "csc",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.csc",
        "description": "Csc observable. Maps to SBML symbol `Csc`."
      },
      {
        "name": "infected_tumor_cells",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.infected_tumor_cells",
        "description": "I observable. Maps to SBML symbol `I`."
      },
      {
        "name": "normal_cells",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.normal_cells",
        "description": "N observable. Maps to SBML symbol `N`."
      },
      {
        "name": "l",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.l",
        "description": "L observable. Maps to SBML symbol `L`."
      },
      {
        "name": "state",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.state",
        "description": "Full raw SBML observable record for reproducibility and downstream visualisation."
      },
      {
        "name": "summary",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.summary",
        "description": "Change and peak summary across the simulated SBML observables."
      },
      {
        "name": "species_labels",
        "maps_to": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.species_labels",
        "description": "Mapping from selected raw SBML observable symbols to display labels."
      }
    ]
  },
  "tags": [
    "angiogenesis",
    "biomodels_ebi",
    "chemotherapy",
    "curated",
    "drug-response",
    "faithful",
    "microenvironment",
    "oncology",
    "pharmacology",
    "physiology",
    "sbml",
    "systemsbiology",
    "tumor-growth"
  ],
  "title": "Mpekris2017 - Role of vascular normalization in benefit from metronomic chemotherapy Lab",
  "models": [
    {
      "path": "owned/models/oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model",
      "alias": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model",
      "provenance": {
        "owned_path": "owned/models/oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model"
      }
    },
    {
      "path": "owned/models/visualisation",
      "alias": "visualisation",
      "provenance": {
        "owned_path": "owned/models/visualisation"
      }
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model_state"
      ],
      "from": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.state"
    },
    {
      "to": [
        "visualisation.oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model_summary"
      ],
      "from": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.summary"
    },
    {
      "to": [
        "visualisation.oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model_species_labels"
      ],
      "from": "oncology_sbml_mpekris2017_role_of_vascular_normalization_in_be_model2001200002_model.species_labels"
    }
  ],
  "runtime": {
    "duration": 10,
    "initial_inputs": {},
    "communication_step": 1
  },
  "description": "Role of vascular normalization in benefit from metronomic chemotherapy.Mpekris F1, Baish JW2, Stylianopoulos T3, Jain RK4.Author informationAbstractMetronomic dosing of chemotherapy-defined as frequen. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
  "schema_version": "2.0"
}

Sign in to start your own run. Public-lab history stays visible here.

Select a run from History to view its results.